Henrik Sundin sold 70,000 shares in the research company Hamlet Biopharma, where he is a board member, on May 22 through the company HS Compliance Partner. The shares were sold at a price of SEK 7.65 per share, a transaction worth SEK 535,200. The transaction was carried out on Spotlight Stock Market. This is stated in the Swedish Financial Supervisory Authority’s insider register.HS Compliance Partner previously owned 129,954 shares in Hamlet, according to the ownership service Holdings.Sundin also owns an additional 2.23 million shares in Hamlet in his own name.